{
  "main_header": {
    "sid": 324228,
    "name": "Hester Bios",
    "stock_name": "Hester Bios",
    "full_name": "Hester Biosciences Ltd",
    "name_url": "stocks-analysis/hester-bios",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,666.85",
    "chg": 68.85,
    "chgp": "4.31%",
    "dir": 1,
    "prev_price": "1,598.00",
    "mcapval": "1,409.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524669,
    "symbol": "HESTERBIO",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE782E01017",
    "curr_date": "Apr 11, 12:52 PM",
    "curr_time": "00:14 AM",
    "bse_nse_vol": "6.4 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hester-bios-324228-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Hester Biosciences Ltd Shows Volatility Amidst Dynamic Pharmaceuticals Market Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-stock-hits-upper-circuit-limit-with-high-price-of-rs-1786-7-1694109",
        "imagepath": "",
        "date": "2025-04-03 10:00:28",
        "description": "Hester Biosciences Ltd, a small-cap player in the Pharmaceuticals & Drugs sector, has experienced significant activity today, hitting its upper circuit limit with a high price of Rs 1786.7. The stock saw a notable change of Rs 297.75, reflecting a 20% increase. Despite opening with a loss of 2.62%, the stock rebounded, showcasing resilience in a fluctuating market.\n\nThroughout the trading session, Hester Biosciences recorded an intraday low of Rs 1510.0, with a total traded volume of approximately 7.23 lakh shares, resulting in a turnover of Rs 122.21 crore. The stock's performance today, however, underperformed the sector by 4.21%, while the broader Pharmaceuticals & Drugs industry gained 3.35%.\n\nIn terms of moving averages, Hester Biosciences is currently above its 5-day, 20-day, and 50-day averages but remains below its 100-day and 200-day averages. The stock's liquidity appears favorable, with a deliver..."
      },
      {
        "title": "Hester Biosciences Shows Mixed Technical Trends Amidst Strong Long-Term Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-stock-price-increase-1692151",
        "imagepath": "",
        "date": "2025-04-03 08:01:30",
        "description": "Hester Biosciences, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 1789.25, showing a notable increase from the previous close of 1504.65. Over the past year, Hester Biosciences has experienced a stock return of 18.78%, outperforming the Sensex, which recorded a return of 3.67% in the same period.\n\nThe technical summary indicates a mixed performance across various indicators. The MACD shows bearish signals on both weekly and monthly charts, while the Bollinger Bands reflect a mildly bearish stance. The daily moving averages also align with this trend. However, the KST presents a contrasting view with a bullish signal on the monthly chart, suggesting some underlying strength.\n\nIn terms of stock performance, Hester Biosciences has faced challenges over longer periods, with a year..."
      },
      {
        "title": "Hester Biosciences Surges 18.91% Amid Strong Buying Activity and Market Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-surges-18-91-today-achieves-31-16-weekly-gain-amid-strong-buying-activity-1679103",
        "imagepath": "",
        "date": "2025-04-02 15:05:07",
        "description": "Hester Biosciences Ltd is currently witnessing significant buying activity, with the stock gaining 18.91% today, markedly outperforming the Sensex, which rose by only 0.86%. Over the past week, Hester has shown a remarkable increase of 31.16%, while the Sensex declined by 0.79%. This strong performance is notable given that the stock has been on a consecutive gain streak for the last two days, accumulating a total return of 42.69% during this period.\n\nDespite opening with a gap down of 3.32%, Hester Biosciences reached an intraday high of Rs 1789.25, showcasing its volatility with a day’s low of Rs 1454.7. The stock's performance over the past month reflects a 21.39% increase, contrasting with the Sensex's 4.75% gain. \n\nFactors contributing to the buying pressure may include recent developments in the pharmaceuticals sector, investor sentiment, or company-specific news. Hester's current price is above its 5..."
      },
      {
        "title": "Hester Biosciences Stock Surges Amid Strong Investor Demand and Trading Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-stock-hits-upper-circuit-with-intraday-high-of-rs-1645-9-1672541",
        "imagepath": "",
        "date": "2025-04-02 10:00:28",
        "description": "Hester Biosciences Ltd, a small-cap player in the Pharmaceuticals & Drugs sector, has made headlines today as its stock hit the upper circuit limit, closing at an impressive high price of Rs 1,505.4. This marks a significant change of Rs 250.9, reflecting a 20% increase in value. The stock's performance has outpaced its sector, delivering returns of 11.39% for the day, while the broader sector experienced a slight decline of 0.25%.\n\nDuring trading, Hester Biosciences reached an intraday high of Rs 1,645.9, showcasing a robust demand for its shares. The stock traded a total volume of approximately 3.00 lakh shares, resulting in a turnover of Rs 43.88 crore. Notably, the stock has been on a positive trajectory, gaining 29.09% over the last two days.\n\nIn terms of liquidity, the stock remains accessible for trading, with a delivery volume that has surged by nearly 198% compared to its five-day average. Overall,..."
      },
      {
        "title": "Hester Biosciences Shows Volatility Amid Broader Market Resilience and Sector Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-stock-rises-9-64-amid-broader-market-gains-1672500",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/HesterBioscienc_priceRelatedfactors_863435.png",
        "date": "2025-04-02 09:45:18",
        "description": "Hester Biosciences has shown notable stock activity, gaining 9.64% on April 2, 2025, and outperforming its sector. The stock has experienced a total return of 29.66% over two days, despite earlier losses. Broader market conditions remain positive, with the Sensex also climbing."
      },
      {
        "title": "Hester Biosciences Adjusts Valuation Grade Amid Competitive Pharmaceutical Landscape",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-sees-valuation-grade-shift-from-expensive-to-very-expensive-1669904",
        "imagepath": "",
        "date": "2025-04-02 08:00:40",
        "description": "Hester Biosciences, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone a valuation adjustment, reflecting a shift in its financial standing. The company's current price stands at 1504.65, showing a notable increase from the previous close of 1253.90. Over the past year, Hester has experienced a stock return of 3.78%, outperforming the Sensex, which returned 2.72% in the same period.\n\nKey financial metrics indicate a PE ratio of 41.09 and an EV to EBITDA of 26.08, positioning Hester in a competitive landscape. The company's PEG ratio is 0.60, suggesting a favorable growth outlook relative to its earnings. However, its return on capital employed (ROCE) is at 8.89%, and return on equity (ROE) is 7.78%, which may warrant further scrutiny.\n\nIn comparison to its peers, Hester's valuation metrics reveal a diverse landscape. While Hester is categorized as very expensive, competitors li..."
      },
      {
        "title": "Hester Biosciences Shows Strong Rebound Amid Market Volatility and Active Trading",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-stock-hits-upper-circuit-limit-with-intraday-high-of-rs-1505-4-1662065",
        "imagepath": "",
        "date": "2025-04-01 12:00:10",
        "description": "Hester Biosciences Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, has experienced significant activity today, hitting its upper circuit limit. The stock reached an intraday high of Rs 1505.4, reflecting a robust price movement of 20% from its previous close. This surge comes after a period of four consecutive days of decline, marking a notable trend reversal.\n\nThe stock opened with a gain of 2.35% and has since demonstrated strong performance, outperforming its sector by 16.8%. The total traded volume reached approximately 1.62 lakh shares, contributing to a turnover of Rs 23.69 crore. The stock has shown a wide trading range of Rs 237.4 throughout the day, indicating active market participation.\n\nDespite the recent volatility, Hester Biosciences has maintained a weighted average price closer to its low price, suggesting a shift in investor sentiment. The stock's 1D return stands at 15.42%..."
      },
      {
        "title": "Hester Biosciences Shows Resilience Amid Broader Market Decline and Mixed Technical Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-gains-15-98-amid-broader-market-decline-on-april-1-2025-1659708",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/HesterBioscienc_priceRelatedfactors_851925.png",
        "date": "2025-04-01 11:40:23",
        "description": "Hester Biosciences has seen a notable increase on April 1, 2025, reversing a four-day decline and reaching an intraday high. While it outperformed its sector, the stock's longer-term performance indicates significant declines year-to-date and over the past three years, contrasting with broader market trends."
      },
      {
        "title": "Hester Biosciences Faces Continued Stock Decline Amid Broader Market Resilience",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-stock-hits-52-week-low-amid-ongoing-decline-in-market-performance-1646430",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/HesterBioscienc_priceRelatedfactors_845241.png",
        "date": "2025-03-28 15:00:20",
        "description": "Hester Biosciences has faced notable volatility, with its stock reaching a new 52-week low and experiencing four consecutive days of losses. The company has underperformed its sector significantly, trading below all key moving averages. In contrast, the broader market has shown modest gains, highlighting Hester's ongoing challenges."
      }
    ],
    "total": 3421,
    "sid": "324228",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/hester-biosciences-324228"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Apr-2025",
      "details": "Confirmation Certificate for the quarter ended 31 March 2025",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "04-Apr-2025",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Hester Biosciences Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L99999GJ1987PLC022333</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>22.93</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>CAREBBB+STABLE</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>CARE RATINGS LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Vinod Mali <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: vinod.mali@hester.in</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Divyesh Maru <br/> Designation: Chief Financial Officer <br/> EmailId: cs@hester.in</div> </div> <div> <br/> Date: 04/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2025",
      "details": "Notice for closure of Trading Window of the Company",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has declared <strong>60%</strong> dividend, ex-date: 22 Aug 24",
          "dt": "2024-08-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 27 Sep 12",
          "dt": "2012-09-27",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>2:5</strong> rights issue, ex-date: 29 May 06",
          "dt": "2006-05-29",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Hester Biosciences Ltd Shows Volatility Amidst Dynamic Pharmaceuticals Market Activity

2025-04-03 10:00:28

Hester Biosciences Ltd, a small-cap player in the Pharmaceuticals & Drugs sector, has experienced significant activity today, hitting its upper circuit limit with a high price of Rs 1786.7. The stock saw a notable change of Rs 297.75, reflecting a 20% increase. Despite opening with a loss of 2.62%, the stock rebounded, showcasing resilience in a fluctuating market. Throughout the trading session, Hester Biosciences recorded an intraday low of Rs 1510.0, with a total traded volume of approximately 7.23 lakh shares, resulting in a turnover of Rs 122.21 crore. The stock's performance today, however, underperformed the sector by 4.21%, while the broader Pharmaceuticals & Drugs industry gained 3.35%. In terms of moving averages, Hester Biosciences is currently above its 5-day, 20-day, and 50-day averages but remains below its 100-day and 200-day averages. The stock's liquidity appears favorable, with a deliver...

Read More

Hester Biosciences Shows Mixed Technical Trends Amidst Strong Long-Term Performance

2025-04-03 08:01:30

Hester Biosciences, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 1789.25, showing a notable increase from the previous close of 1504.65. Over the past year, Hester Biosciences has experienced a stock return of 18.78%, outperforming the Sensex, which recorded a return of 3.67% in the same period. The technical summary indicates a mixed performance across various indicators. The MACD shows bearish signals on both weekly and monthly charts, while the Bollinger Bands reflect a mildly bearish stance. The daily moving averages also align with this trend. However, the KST presents a contrasting view with a bullish signal on the monthly chart, suggesting some underlying strength. In terms of stock performance, Hester Biosciences has faced challenges over longer periods, with a year...

Read More

Hester Biosciences Surges 18.91% Amid Strong Buying Activity and Market Outperformance

2025-04-02 15:05:07

Hester Biosciences Ltd is currently witnessing significant buying activity, with the stock gaining 18.91% today, markedly outperforming the Sensex, which rose by only 0.86%. Over the past week, Hester has shown a remarkable increase of 31.16%, while the Sensex declined by 0.79%. This strong performance is notable given that the stock has been on a consecutive gain streak for the last two days, accumulating a total return of 42.69% during this period. Despite opening with a gap down of 3.32%, Hester Biosciences reached an intraday high of Rs 1789.25, showcasing its volatility with a day’s low of Rs 1454.7. The stock's performance over the past month reflects a 21.39% increase, contrasting with the Sensex's 4.75% gain. Factors contributing to the buying pressure may include recent developments in the pharmaceuticals sector, investor sentiment, or company-specific news. Hester's current price is above its 5...

Read More

Hester Biosciences Stock Surges Amid Strong Investor Demand and Trading Activity

2025-04-02 10:00:28

Hester Biosciences Ltd, a small-cap player in the Pharmaceuticals & Drugs sector, has made headlines today as its stock hit the upper circuit limit, closing at an impressive high price of Rs 1,505.4. This marks a significant change of Rs 250.9, reflecting a 20% increase in value. The stock's performance has outpaced its sector, delivering returns of 11.39% for the day, while the broader sector experienced a slight decline of 0.25%. During trading, Hester Biosciences reached an intraday high of Rs 1,645.9, showcasing a robust demand for its shares. The stock traded a total volume of approximately 3.00 lakh shares, resulting in a turnover of Rs 43.88 crore. Notably, the stock has been on a positive trajectory, gaining 29.09% over the last two days. In terms of liquidity, the stock remains accessible for trading, with a delivery volume that has surged by nearly 198% compared to its five-day average. Overall,...

Read More

Hester Biosciences Shows Volatility Amid Broader Market Resilience and Sector Outperformance

2025-04-02 09:45:18

Hester Biosciences has shown notable stock activity, gaining 9.64% on April 2, 2025, and outperforming its sector. The stock has experienced a total return of 29.66% over two days, despite earlier losses. Broader market conditions remain positive, with the Sensex also climbing.

Read More

Hester Biosciences Adjusts Valuation Grade Amid Competitive Pharmaceutical Landscape

2025-04-02 08:00:40

Hester Biosciences, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone a valuation adjustment, reflecting a shift in its financial standing. The company's current price stands at 1504.65, showing a notable increase from the previous close of 1253.90. Over the past year, Hester has experienced a stock return of 3.78%, outperforming the Sensex, which returned 2.72% in the same period. Key financial metrics indicate a PE ratio of 41.09 and an EV to EBITDA of 26.08, positioning Hester in a competitive landscape. The company's PEG ratio is 0.60, suggesting a favorable growth outlook relative to its earnings. However, its return on capital employed (ROCE) is at 8.89%, and return on equity (ROE) is 7.78%, which may warrant further scrutiny. In comparison to its peers, Hester's valuation metrics reveal a diverse landscape. While Hester is categorized as very expensive, competitors li...

Read More

Hester Biosciences Shows Strong Rebound Amid Market Volatility and Active Trading

2025-04-01 12:00:10

Hester Biosciences Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, has experienced significant activity today, hitting its upper circuit limit. The stock reached an intraday high of Rs 1505.4, reflecting a robust price movement of 20% from its previous close. This surge comes after a period of four consecutive days of decline, marking a notable trend reversal. The stock opened with a gain of 2.35% and has since demonstrated strong performance, outperforming its sector by 16.8%. The total traded volume reached approximately 1.62 lakh shares, contributing to a turnover of Rs 23.69 crore. The stock has shown a wide trading range of Rs 237.4 throughout the day, indicating active market participation. Despite the recent volatility, Hester Biosciences has maintained a weighted average price closer to its low price, suggesting a shift in investor sentiment. The stock's 1D return stands at 15.42%...

Read More

Hester Biosciences Shows Resilience Amid Broader Market Decline and Mixed Technical Outlook

2025-04-01 11:40:23

Hester Biosciences has seen a notable increase on April 1, 2025, reversing a four-day decline and reaching an intraday high. While it outperformed its sector, the stock's longer-term performance indicates significant declines year-to-date and over the past three years, contrasting with broader market trends.

Read More

Hester Biosciences Faces Continued Stock Decline Amid Broader Market Resilience

2025-03-28 15:00:20

Hester Biosciences has faced notable volatility, with its stock reaching a new 52-week low and experiencing four consecutive days of losses. The company has underperformed its sector significantly, trading below all key moving averages. In contrast, the broader market has shown modest gains, highlighting Hester's ongoing challenges.

Read More

View All News